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Review
Improving quality of care for end-stage
respiratory disease: Changes in attitude,
changes in service
D Robin Taylor1,2 and Scott A Murray3
Abstract
The illness trajectory for many patients with severe respiratory disease is characterized by steady decline. Yet
most healthcare resources are poured into managing acute exacerbations that are only temporarily effective.
Further, ‘bad deaths’ can result from inappropriate medical interventions at times of crisis. In this article, we
describe a range of changes in attitudes, behaviour and service provision that together focus on improving
quality of care for respiratory patients with frequent crises. These changes include prognostic conversations,
developing and implementing anticipatory care plans both in hospital and in the outpatient settings, and
establishing a supportive care clinic devoted to complex disease and optimizing palliative care. The
underpinning philosophy is that common sense and compassion should motivate broader and more flexible
care much more than adherence to the ‘curative–restorative’ guidelines-based model.
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Introduction
Chronic obstructive pulmonary disease (COPD) is a
leading cause of morbidity and mortality in most
Western countries. In the United Kingdom, 5.3% of
all deaths in 2012 were attributed to COPD as the
primary cause.1
The trajectory of physical decline for patients with
COPD is very variable (see Figure 1).2 It includes
partially reversible episodes of decompensation
against a background of irreversible deterioration in
respiratory health. A range of comorbidities increase
the risk of death during acute exacerbations, but the
risk factors for mortality in the long-term are differ-
ent.3 There are no reliable physiological markers that
predict survival in individual patients. Only exacerba-
tion frequency has prognostic significance. Once a
patient has had two or more acute exacerbations of
COPD (AECOPD), the likelihood of accelerated
decline and death is significantly increased.4 In one
study, the risk of mortality after the first exacerbation
requiring noninvasive ventilatory support was 28% at
1 year, 48% at 2 years and 74% at 5 years.5
These data have underpinned the emphasis that
researchers and clinicians place on interventions
designed to reduce the frequency and severity of
AECOPDs and, it is assumed, mortality. Yet the
impact of most therapies is limited: only pulmonary
rehabilitation appears to have a significant benefit on
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exacerbation frequency,6 but whether it reduces mor-
tality is unknown.
What these data have not done is to shift the
emphasis of treatment towards palliative and suppor-
tive care despite the World Health Organization rec-
ommendation that these should be integrated into the
care of all life-limiting conditions.7 The majority of
patients with severe COPD experience refractory
symptoms as well as psychological and spiritual stres-
ses that result in needs that are poorly met. This is
reflected in the fact that there are no substantial stud-
ies that have examined the benefits of holistic inter-
ventions in COPD.8 It is also reflected in the fact that
services for COPD are often less accessible than for
patients with lung cancer.
Why is it that care for patients with end-stage
COPD is suboptimal? The obstacles are multiple.
There is failure by both clinicians and patients to
recognize that COPD is a potentially life-limiting
condition. Further, most clinicians (but only a minor-
ity of patients) are reluctant to engage in prognostic
conversations, often because of uncertainty.9,10 In
turn, this leads to a neglect of anticipatory (advance)
care planning (ACP) and of early palliative care.11,12
The same reluctance goes hand in hand with thinking
that the primary goal of treatment should be curative–
restorative, especially when treating AECOPDs. This
is despite the fact that the gains are limited and ‘inten-
tion-to-cure’ often conflicts with the values and pre-
ferences that most patients express during the last year
of life.13
Systemic failures
These failings have been identified for some time, and
yet overall, little has changed in service provision for
COPD patients. Our personal view is that the problem
is greater than the attitudes and behaviours of individ-
ual clinicians. It is that in addition, clinicians function,
often complicitly, within a healthcare system that is
still shaped by the pre-eminence of the ‘fix-it’
paradigm.
These issues were brought into sharp focus for one
of the present authors (DRT) when a 78-year-old
patient with end-stage COPD was admitted under his
care with a further AECOPD that was recognized as a
terminal event. In spite of a relevant end-of-life con-
versation and optimizing palliative treatments, when
the patient became more distressed during the night,
the on-call staff responded by obtaining three arterial
blood gas samples, setting up an aminophylline infu-
sion and commencing noninvasive ventilation. He
had previously refused this treatment. He died 3 hours
later. Thus, the admission concluded with a ‘bad
death’ and a complaint was lodged by his family.14
In the subsequent enquiry, several major issues
were highlighted. Firstly, although an end-of-life con-
versation and desired palliative treatments were ade-
quately documented and given, what was NOT
documented was what ought NOT to be done. Sec-
ondly, and for this very reason, the doctor involved
was unclear about what to do. He therefore adhered to
the protocol for managing acute respiratory failure
even though this was an entirely inappropriate
decision.
Later, a hospital-wide mortality audit (not limited
to respiratory deaths) revealed that this pattern of
events was occurring not infrequently, that is, proto-
cols for managing acute medical crises were being
followed without regard to the context in which care
was being delivered. Often interventions were futile,
burdensome and contrary to the patient’s wishes. This
picture is well described for cardiopulmonary resus-
citation (CPR) and for admissions to intensive care
unit, but the problem is more widespread.15
Overtreatment with curative–restorative treatments
and undertreatment with palliative measures were
systemic, leading to harm in patients whose vulner-
ability was greatest. Only rarely was there careless-
ness or incompetence on the part of individual doctors
or nurses. The adverse outcomes were driven by a
complex mix comprising the absence of timely
decision-making and communication about prognosis
Figure 1. A stylized model depicting the end-of-life tra-
jectory for a proportion of patients with COPD. Uncer-
tainty at the time of acute exacerbations often drives an
emphasis on achieving short-term goals while neglecting
the overall trend. Adapted from Murray et al.2 COPD:
chronic obstructive pulmonary disease.
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and treatment preferences; discontinuity of care and
the inexperience of on-call staff; adherence to treat-
ment protocols as the default response to crises
(including a rising Early Warning Score); and fear
of censure if intervention was not implemented.
In response, we undertook a radical review of our
approach to managing hospitalized patients with acute
exacerbation on chronic respiratory disease (COPD,
pulmonary fibrosis and some cases of lung cancer). In
the following sections, we describe some of the mea-
sures that we adopted. No single entity has unique
merits. We recognize that many of them are now
being widely adopted and so we make no claims to
having special expertise.
Diagnosing dying and prognostic
conversations
The most important step towards improving care is to
take prognosis seriously – by which we do not mean
addressing the question ‘how long have I got?’ but
rather holding a much broader conversation with
patients about the likely course of events (Table 1).
William Osler said that ‘Medicine is a science of
uncertainty and an art of probability’. This statement
implies that managing rather than avoiding the uncer-
tainty of a patient’s condition is integral to good care.
Gawande has observed that patients need doctors who
are willing to have the hard discussions and help them
prepare for what is to come.16
There is a key reason for making such discussions
normative.17 Firstly, it is a patient’s right to know and
it is a clinician’s ethical responsibility to communi-
cate information and honest opinion about what might
lie ahead. However much uncertainty there may be,
we ought not to hide behind it but share the uncer-
tainty with patients and their carers. Taking account
of what the future may hold – often based on recent
trends and events – creates a perspective that will
almost always shape treatment goals. Things go
always better with planning and that is only possible
when the illness trajectory is taken realistically into
account.
In our multidisciplinary team (MDT), we have
sought to normalize thinking ahead by frequent use
of the surprise question: ‘Would you be surprised if
this patient were to die in the next 6–12 months?’.18
The question encourages intuitive integration of infor-
mation about disease state, comorbidities, and social
and psychological factors in order to consider whether
the patient may be nearing the end of life. The surprise
question has not been validated as a prognostic tool
for patients with lung disease but rather is a general
indicator of downward trends.19
It soon became apparent that even when prog-
nosis is considered in planning patient care, discuss-
ing its implications with patients and relatives is
challenging. Staff reluctance to do so is based on
subjective inadequacies in communication skills,
the death taboo, difficulties in processing uncer-
tainty, the challenges in explaining the technical
complexities of treatment while promoting shared
decision-making and dealing with family members.
We have therefore begun a programme that inte-
grates the topics of discussing dying and having
prognostic conversations into skills training at all
staff levels and have developed appropriate educa-
tional aides.20
The supportive care clinic
We also identified that a major factor affecting clin-
ician’s willingness to hold prognostic conversations is
time and timing.21 There are broadly two types of
anticipatory conversation. The shorter version takes
place at the time of an acute admission for AECOPD
and focuses on interventions and likely outcomes that
are relevant for the next few hours/days. The second
focuses on longer term management and includes
broader ACP. Dealing with these issues during a hos-
pital admission can be difficult. Even if time is
available, the patient may not be ready for the
conversation.
Table 1. Examples of starting-point questions for
prognostic conversations.a
‘John, things seem to have changed for you over the last few
months . . . have you noticed that?’
‘Mary, given all that’s been happening to you lately, what are
your thoughts about the future?’
‘I think we can get you well again this time (severe
AECOPD), but have you thought much about what you
might like us to do for you further down the track?’
‘John, do you worry about the way things have been
heading?’
‘Mary, can you tell me a little bit about what you are
frightened of’.
AECOPD: acute exacerbation of chronic obstructive pulmonary
disease.
aThe aim is to help patients to reflect on trends and events in the
recent past and to use that reflection as the basis for considering
the likely future course of their health. Establishing appropriate
goals of care and treatment can emerge from this approach.
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To deal with this, we set up a Supportive Care
Clinic. The criteria for referral were (a) the patient
was admitted on two or more occasions with
AECOPD and (b) the answer to the surprise question
was ‘No, I would not be surprised if . . . ’, as judged at
a MDT meeting. The clinics were led by a consultant
respiratory physician and a respiratory nurse special-
ist. Clinic appointments were for 45 minutes. Family
members were invited. In addition to providing ade-
quate time for prognostic conversations and the map-
ping of an ACP, the scope included optimizing
palliative treatment of dyspnoea, addressing anxiety
and depression, assessing pulmonary rehabilitation
and/or long-term oxygen, managing cor pulmonale
and considering long-term antibiotics and nutrition.
A similar approach has been outlined in more detail
by Steiner et al.22 Hospital managers insisted that this
endeavour had to be contained within existing clinic
times and budgets. Given our commitment to priori-
tize care for patients at the end of life, we therefore
reduced ‘routine’ COPD appointments by modifying
the referral criteria for less severe disease.
The Supportive Care Clinic sought to provide a so-
called care bundle that was shaped by the patient’s
illness trajectory. Prognostic conversations, ACP and
palliative treatments are now recommended in
evidence-based guidelines as an integral part of care
for patients with COPD.23 However, it is disappoint-
ing that none of these key elements was included
among the 26 components that have been variously
included in 14 studies of discharge care bundles for
patients with COPD. Although implementing ‘care
bundles’ significantly reduces hospital readmissions,
and this is a legitimate goal, they have no impact on
quality of life or mortality.24 Clearly, there is a dis-
crepancy between guidelines’ recommendations and
the scope of emerging services for patients with
COPD that urgently needs to be addressed.
Anticipatory (advance) care planning
Integral to the work of the Supportive Care Clinic was
the development of a disease-specific ACP for
patients with respiratory disease. Their value in
COPD is increasingly recognized.12,25 Our plan
(see Online Supplement 1: ‘Making Choices’) includes
generic elements common to most ACPs, for example,
care arrangements when dependency increases, place
of death, welfare power of attorney and will and fun-
eral arrangements. It also includes components that are
specific to the management of end-stage COPD/
interstitial lung disease, for example, escalation/limita-
tion of treatment during future AECOPDs.
However, we were obliged to learn a number of
important lessons – born of the frustration and failure
that is commonly experienced with ACPs.26 Impor-
tantly, leading a patient and their carer through an
ACP should aim to create a shared mindset. That is
far more important than the completion of documen-
tation. Indeed, a proportion of patients shy away from
a written plan if this is perceived to be the chief aim.
Planning how to manage future crises (transfer to
hospital, noninvasive or mechanical ventilation, CPR,
etc.) is important, but this has to be nested within
something broader. The key issues are not narrowly
clinical, and it is helpful to approach clinical issues
via a set of wider questions. They encourage thinking
about the ‘bucket list’, meaningful relationships,
letting go versus clinging on, life after death and pre-
paration of the soul, anticipating loss and bereave-
ment for the next of kin (see Table 2).
Treatment escalation/limitation
Finally, in response to the problems highlighted by
our index case and to reduce the potential for misman-
aged AECOPDs and ‘bad deaths’ in our hospital
ward, we developed what is now termed a treatment
escalation/ limitation plan (TELP) (but known in
our locality as the Hospital ACP (see Online
Supplement 2)).
TELPs are increasingly accepted as an important
adjunct to managing unstable or end-of-life patients,
and there is now a national initiative in the United
Kingdom to introduce the concept more widely.27 The
historical precedent is the Do Not Attempt Cardiopul-
monary Resuscitation (DNACPR) order. By extend-
ing the scope of DNACPR to include a range of
disease-specific interventions, and by ensuring that a
summary is readily available, the aim is to minimize
harm attributable to overtreatment/undertreatment
and/or discontinuity of care in unstable patients if and
when further deterioration occurs. The use of a TELP
complements what has already been agreed in a pre-
admission ACP. Importantly, its use is not limited to
those who are terminally ill and it does not provide for
treatment withdrawal or an end-of-life care pathway.
Like all forms of advance planning, the successful
use of a TELP is dependent on the willingness of
clinicians to consider and discuss prognosis, to appro-
priately set aside the one-size-fits-all ‘fix it’ approach
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to managing acute medical crises especially at the end
of life and to embrace shared decision-making.
There is an increasing body of evidence to support
the use of TELPs. Firstly, about a third of in-hospital
emergency team call-outs involve patients who are at
the end of life and for whom the need for palliative
care has not been previously considered.28 These call-
outs can result in inappropriate overtreatment. Sec-
ondly, between 30% and 40% of major medical
interventions prove to be nonbeneficial when applied
in the last year of life.15Thirdly, in terminal illness, there
is an inverse relationship between the intensity of med-
ical interventions and patients’ quality of death as
judged by their next of kin.29 Fourthly, when a TELP
is introduced, there is a highly significant reduction in
medical harms in hospital, primarily due to avoiding
inappropriate interventions.30 Finally, when advance
planning (TELP or ACP) is used, there is significantly
greater concordance between a patient’s preferences
and the care that is delivered, and this is associated
with a reduction in levels of anxiety and depression
experienced by their family members.31
Conclusion
No single intervention in itself improves quality of
care for patients with progressive respiratory disease,
especially towards the end of life. Rather a strategy is
required that begins by acknowledging that present
practices are ineffective or worse, are causing harm,
and then embraces a range of pragmatic solutions.
What we have described here includes changes not
just to individual behaviour and decision-making (for
example, prognostic conversations, palliative care
sooner rather than later), but also to the services that
are provided by the health system (for example, the
supportive care clinic). There is a dynamic two-way
interaction between using tools and aides to improve
care quality and the culture change that is essential in
order for them to be effective.
The management of life-limiting respiratory dis-
ease begins with an attitude that is realistic and com-
passionate and is willing to go beyond the constraints
both of the curative medical model and of the present
healthcare system. Where traditional disease-oriented
evidence-based guidelines and clinical behaviours are
Table 2. Questions and specimen answers used in ‘Making Choices, an Anticipatory Care Plan for patients with chronic
respiratory disease’ a disease-specific ACP (see Online Supplement 1).
Question Sample answer
If you have been experiencing deterioration in your overall
condition, including your breathing, how do you think
these problems are going to affect you in the future?
I am concerned that I will not be able to get out of the house.
When you are thinking about your future or about dying,
what is it that worries you most?
I think about how I might die. I worry that I am going to suffocate
and it will be a struggle to breathe at the very last.
Based on your view of how things are developing OR past
experiences you have had, are there any treatments
which you would not wish to have in the event of sudden
deterioration?
I get claustrophobic when they put a mask over my face. This
happened when I was on NIV treatment. It made me much
more anxious.
Under what circumstances would you want the goal of
medical care to switch from actively attempting to
prolong your life to focusing on supportive/comfort care?
If I get a bad pneumonia and it’s definite that I am dying even
despite lots of treatment, then I would be comfortable if
antibiotics were stopped.
Where would you prefer to spend your last few weeks or
days?What would be your ideal surroundings at this time?
How could this happen?
I do not want to be in a noisy hospital ward. If possible, I would
prefer to be at home but that depends on how my family feel. If
it’s available, it would be good to be admitted to the hospice.
Are your goals affected by your present state of health? Are
there ways in which help might be provided so that you
can accomplish your goals?
It is really important that I spend time with my daughter and my 2
grandchildren. I could visit them if it was possible for the
oxygen concentrator to be transported to their house for a
weekend.
What would help you live your life better from now on? Knowing that when the end is near, I can get help easily. I live on
my own.
When you are nearing the end, and may not be able to speak
or be understood, are there things you would like your
family or friends to know?
I would like my ex-husband to know that I have forgiven him. I
would like my son who lives in Australia to know that I love him
very much and am very proud of him.
ACP: anticipatory (advance) care plan.
Taylor and Murray 5
in conflict with compassion and common sense, then
the latter should be given priority.
Authors’ Note
Readers may be interested to view ‘A Good Death’ that
deals with this topic narratively. It depicts medical care
during the last 14 months of the life of a patient with severe
COPD. https://vimeo.com/39258619 (free to view)
Declaration of conflicting interests
The author(s) declared no potential conflicts of interest
with respect to the research, authorship, and/or publication
of this article.
Funding
The author(s) received no financial support for the
research, authorship, and/or publication of this article.
Supplemental material
The online data supplements are available at http://journal
s.sagepub.com/doi/suppl/10.1177/1479972317707654.
References
1. British Lung Foundation. https://statistics.blf.org.uk,
2012.
2. Murray SA, Kendall M, Boyd K, et al. Illness trajec-
tories and palliative care. BMJ 2005; 330: 1007–1011.
3. Singanayagam A, Schembri S and Chalmers JD. Pre-
dictors of mortality in hospitalised adults with acute
exacerbations of chronic obstructive airways disease.
Ann Am Thorac Soc 2013; 10(2): 81–89.
4. Suissa S, Dell’Aniello S and Ernst P. Long-term natu-
ral history of chronic obstructive pulmonary disease:
severe exacerbations and mortality. Thorax 2012; 67:
957–963.
5. Chung LP, Winship P, Phung S, et al. Five-year out-
come in COPD patients after their first episode of acute
exacerbation treated with non-invasive ventilation.
Respirology. 2010; 15: 1084–1091.
6. Ochmann U, Jo¨rres RA and Nowak D. Long-term effi-
cacy of pulmonary rehabilitation: a state-of-the-art
review. J Cardiopulm Rehabil Prev 2012; 32: 117–126.
7. World Health Assembly. Strengthening of palliative
care as a component of integrated treatment within the
continuum of care. 134th Session of the World Health
Assembly. EB134.R7, 2014.
8. Nurmatov U, Buckingham S, Kendall M, et al. Effec-
tiveness of holistic interventions for people with severe
chronic obstructive pulmonary disease: systematic
review of controlled clinical trials. PLoS One 2012;
7(10): e46433. DOI: 10.1371/journal.pone.0046433.
9. Momen N, Hadfield P, Kuhn I, et al. Discussing an
uncertain future: end-of-life care conversations in
chronic obstructive pulmonary disease. A systematic
literature review and narrative synthesis. Thorax 2012;
67: 777–780.
10. Pinnock H, Kendall M, Murray SA, et al. Living and
dying with severe chronic obstructive pulmonary dis-
ease: multi-perspective longitudinal qualitative study.
BMJ 2011; 342: d142.
11. Diaz-Lobato S, Smyth D and Curtis JR. Improving
palliative care for patients with COPD. Eur Respir J
2015; 46: 596–598.
12. Patel K, Janssen DJ and Curtis JR. Advance care plan-
ning in COPD. Respirology 2012; 17: 72–78.
13. Wright AA, Zhang B, Ray A, et al. Associations
between end-of-life discussions, patient mental health,
medical care near death, and caregiver bereavement
adjustment. JAMA 2008; 300(14): 1665–1673.
14. Taylor DR. COPD, end of life and ceiling of treatment.
Thorax 2014; 69: 498–500. DOI: 10.1136/
thoraxjnl-2013-204943.
15. Cardona-Morrell M, Kim JCH, Turner RM, et al.
Non-beneficial treatments at the end of life: a systema-
tic review on the extent of the problem. Int J Qual
Health Care 2016; 28(4): 456–469. DOI: 10.1093/
intqhc/mzw060.
16. Gawande A. Being mortal: illness, medicine and what
matters in the end. London: Profile Books, 2014.
17. Christakis NA. Death foretold: prophecy and prog-
nosis in medical care. Chicago: University of Chicago
Press, 1999.
18. Lynn J, Schall MW, Milne C, et al. Quality improve-
ments in end of life care: insights from two collabora-
tives. Jt Comm J Qual Improv 2000; 26: 254–267.
19. Murray SA and Boyd K. Using the ‘surprise question’
can identify people with advanced heart failure and
COPD who would benefit from a palliative care
approach. Palliat Med 2011; 25(4): 382
20. Discussing Dying. NHS Education Scotland. Open
access on VIMEO, 2016. https://vimeo.com/
170436673.
21. Kaplan RS, Haas DA and Warsh J. Adding value by
talking more. N Engl J Med 2016; 375:1918–1920.
22. Steiner MC, Evans RA, Greening NJ, et al. Compre-
hensive respiratory assessment in advanced COPD: a
campus to clinic translational framework. Thorax
2015; 70: 805–808.
23. Siouta N, Van Beek K, Preston N, et al. Towards inte-
gration of palliative care in patients with chronic heart
failure and chronic obstructive pulmonary disease: a
systematic review of European guidelines and
6 Chronic Respiratory Disease 0(0)
pathways. BMJ Palliat Care 2016; 15: 18. DOI: 10.
1186/s12904-016-0089-4.
24. Ospina M, Mrklas K, Deuchar L, et al. A systematic
review of the effectiveness of discharge care bundles
for patients with COPD. Thorax 2017; 72: 31–39.
25. Heffner J. Advance care planning in chronic obstruc-
tive pulmonary disease: barriers and opportunities.
Curr Opin Pulm Med 2011; 17: 103–109.
26. Boddy J, Chenoweth L, McLennan V, et al. It’s just too
hard! Health care practitioner perspectives on barriers
to advance care planning. Aust J Prim Health 2013; 19:
38–45.
27. Resuscitation Council (UK). Recommended Summary
Plan for Emergency Care and Treatment Plan.
2014–2017. https://www.resus.org.uk/consultations/
respect/
28. Jones D, Moran J, Winters B, et al. The rapid response
system and end-of-life care. Curr Opin Crit Care 2013;
19: 616–623.
29. Zhang B, Wright AA, Huskamp HA, et al. Health care
costs in the last week of life: associations with
end-of-life conversations. Arch Int Med 2009; 169:
480–488.
30. Fritz Z and Fuld JP. Development of the Universal
Form Of Treatment Options (UFTO) as an alternative
to Do Not Attempt Cardiopulmonary Resuscitation
(DNACPR) orders: a cross-disciplinary approach. J
Eval Clin Pract 2015; 21: 109–117.
31. Detering KM, Hancock AD, Reade MC, et al. The
impact of advance care planning on end of life care
in elderly patients: randomised controlled trial. BMJ
2010; 340: c1345.
Taylor and Murray 7
